Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk of Neoplasia”

6,371 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,371 results

Not applicableStudy completedNCT02579551
What this trial is testing

Effectiveness of Narrow Margins in Patients With Low-Risk Basal Cell Carcinoma Undergoing Surgery

Who this might be right for
Skin Basal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 179
Early research (Phase 1)Ended earlyNCT02641002
What this trial is testing

CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Celgene 28
Not applicableStudy completedNCT02559557
What this trial is testing

Culturally Adapted Parenting Intervention for Spanish-Speaking Parents in Improving Outcomes of Younger Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Survivors at Risk for Late Neurocognitive Effects

Who this might be right for
Cancer SurvivorChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in Remission+1 more
City of Hope Medical Center 38
Testing effectiveness (Phase 2)Ended earlyNCT02648919
What this trial is testing

Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Hawaii 6
Testing effectiveness (Phase 2)Study completedNCT02794428
What this trial is testing

Chemoprevention of Gastric Carcinogenesis

Who this might be right for
Gastric CancerGastric Intestinal Metaplasia
Vanderbilt-Ingram Cancer Center 91
Testing effectiveness (Phase 2)Ended earlyNCT01543802
What this trial is testing

Study of Preoperative Therapy With Pazopanib (Votrient®) to Treat High-risk Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft-tissue
Heidelberg University 21
Not applicableStudy completedNCT06231537
What this trial is testing

Visual Oral Examination for Early Detection of Oral Cancer in High-Risk Individuals

Who this might be right for
Mouth Neoplasms
Universidade Federal do Rio de Janeiro 1,152
Not applicableLooking for participantsNCT06509945
What this trial is testing

Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Not applicableUnknownNCT05430737
What this trial is testing

A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer

Who this might be right for
Prostate CancerStereotactic Body RadiotherapyHigh-risk+2 more
West China Hospital 60
Large-scale testing (Phase 3)Study completedNCT00002875
What this trial is testing

Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma

Who this might be right for
Brain TumorsCentral Nervous System Tumors
Children's Oncology Group 421
Large-scale testing (Phase 3)Looking for participantsNCT06401330
What this trial is testing

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

Who this might be right for
Stage I Mixed Cell Type Kidney Wilms TumorStage II Mixed Cell Type Kidney Wilms TumorStage III Mixed Cell Type Kidney Wilms Tumor+1 more
Children's Oncology Group 1,656
Testing effectiveness (Phase 2)UnknownNCT01423175
What this trial is testing

ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDS

Who this might be right for
Acute Myeloid LeukemiaMDS
Hannover Medical School 60
Not applicableUnknownNCT01294657
What this trial is testing

Obesity: Cancer Risk Among African Americans

Who this might be right for
CancerObesity
M.D. Anderson Cancer Center 300
Not applicableStudy completedNCT04961619
What this trial is testing

Adjuvant Dabrafenib and Trametinib Treatment in Patients With Completely Resected High-risk Stage III Melanoma.

Who this might be right for
Melanoma
Novartis Pharmaceuticals 39
Not applicableStudy completedNCT01353300
What this trial is testing

Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer

Who this might be right for
Brain and Central Nervous System TumorsHereditary Wilms TumorKidney Cancer+4 more
Children's Oncology Group 31
Not applicableActive Not RecruitingNCT06942845
What this trial is testing

Exploration of Risk Factors for Postoperative Cerebral Infarction in Lung Cancer Patients: a Retrospective Single-centre Study

Who this might be right for
Lung Cancer, Non-Small CellPostoperative Cerebral Infarction
Xinghua Cheng 300
Testing effectiveness (Phase 2)Looking for participantsNCT04996875
What this trial is testing

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Who this might be right for
Advanced Systemic Mastocytosis (AdvSM)SM With an Associated Hematologic Neoplasm (SM-AHN)Mast Cell Leukemia (MCL)+1 more
Cogent Biosciences, Inc. 140
Testing effectiveness (Phase 2)Study completedNCT02729701
What this trial is testing

Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation

Who this might be right for
Breast Cancer
University of Kansas Medical Center 28
Early research (Phase 1)Looking for participantsNCT05292664
What this trial is testing

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Who this might be right for
Myelodysplastic Syndromes, de NovoMyelodysplastic Syndromes, SecondaryMyelodysplastic Syndromes, Previously Treated+8 more
Andrew E. Place, MD 30
Testing effectiveness (Phase 2)Looking for participantsNCT05477264
What this trial is testing

Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type

Who this might be right for
Lymphoma
Won Seog Kim 38
Load More Results